Capital formation challenges in the industry have forced many biotech companies to halt projects, lay off staff or shutdown all together. Our analysis shows that the industry is approximately one-quarter smaller than it was in 2008.
|
September 12, 2011
|
September 12, 2011
|
September 9, 2011
|
September 9, 2011
|
|
August 15, 2011
|
August 11, 2011
|
June 30, 2011
|
June 30, 2011
|